Market Overview
According to fortune business insights, the global fundus camera market size was valued at USD 654.08 million in 2025. The market is projected to grow from USD 691.51 million in 2026 to USD 1,116.81 million by 2034, exhibiting a CAGR of 6.18% during the forecast period. North America dominated the fundus camera market with a market share of 36.40% in 2025.
The analysis shows that the market is driven by the increasing incidence of eye diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. Fundus photography is crucial for diagnosing and monitoring these conditions, which is expected to drive its usage in eye care settings. For instance, the National Center for Biotechnology Information (NCBI) estimated in November 2021 that 22.2% of people with diabetes globally have diabetic retinopathy, indicating a strong clinical need for these devices.
Major Players Profiled in the Market Report:
Segments
Key Advantages to Surge Adoption of Non-Mydriatic Cameras
Based on product type, the market is classified into non-mydriatic cameras, mydriatic cameras, and others. The non-mydriatic cameras segment is expected to hold a significant market share as these devices can capture retinal images without pupil dilation, offering a faster and more patient-friendly experience.
Ease of Use to Drive Handheld Cameras Segment Growth
By portability, the market is classified into tabletop and handheld. The handheld cameras segment is expected to lead and grow significantly due to its portability and ease of use, making it ideal for remote diagnosis and screenings for conditions like diabetic retinopathy.
Rising Incidence to Propel Diabetic Retinopathy Segment
Based on indication, the market is divided into diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), and others. The diabetic retinopathy segment holds a substantial market share, driven by the rising global incidence of the condition, which is projected to affect 190.0 million people by 2030.